… bispecific antibodies by combining nonoverlapping specificities and identified five bispecific
antibodies that inhibit SARS-CoV-… of action, three bispecific antibodies cross-linked adjacent …

… antibodies (B38 and H4) blocking SARS-CoV-2 … bispecific monoclonal antibody (bsAb)
based on B38 and H4. bsAb15 has greater neutralizing efficiency than these parental antibodies, …

… We have shown that the CoV-X2 bispecific antibody is more effective than the related … like
bispecific antibodies are therefore worth adding to the tools that we use to address SARS-CoV-…

… are highly effective in an in vivo model of SARS-CoV-2 infection We tested the bispecific
antibodies for efficacy against SARS-CoV-2 infection in the well-established Syrian hamster …

… two key steps of SARS-CoV-2 entry, we generated a human-derived, IgG1-like bispecific
antibody, Bi-Nab 35B5-47D10 , based on two human neutralizing antibodies, 35B5 and 47D10, …

… SARS-CoV-2 RBD. We generate a bispecific antibody with two antigen-recognition variable
regions from two of the top mAb clones against SARS-CoV-2 RBD. These monospecific and …

… bispecific antibodies using GW01 in combination with the SARS-CoV-2 RBD-specific potent
antibody … We measured the neutralizing activities of these six bispecific antibodies against …

… that our bispecific antibody platform could serve as a universally applicable strategy
against both SARS-CoV-2 and its related strains by simply switching RBD-specific antibodies. …

… bispecific antibodies, we performed a neutralization assay using a panel of twenty-eight
pseudoviruses, including SARS-CoV-2 … as SARS-CoV, WIV1, and RS3367. Remarkably, G7-Fc …

… designed an RBD bispecific antibody that potently neutralizes a range of SARS-CoV-2 variants…
than its parental antibodies against SARS-CoV-2 VBMs and VOCs. Our data indicate that …